T. Rowe Price Investment Management’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.6M Sell
1,225,091
-308,558
-20% -$15.1M 0.04% 355
2026
Q1
$65.5M Sell
1,533,649
-13,619
-0.9% -$566K 0.05% 313
2025
Q4
$61M Sell
1,547,268
-31,499
-2% -$1.25M 0.04% 326
2025
Q3
$65.7M Sell
1,578,767
-221,224
-12% -$9.76M 0.04% 337
2025
Q2
$84.2M Sell
1,799,991
-29,009
-2% -$1.19M 0.05% 306
2025
Q1
$73.2M Buy
1,829,000
+138,111
+8% +$5.39M 0.05% 334
2024
Q4
$64.7M Buy
1,690,889
+1,215,948
+256% +$48.5M 0.04% 361
2024
Q3
$18.9M Buy
474,941
+192,397
+68% +$8.05M 0.01% 522
2024
Q2
$11.1M Buy
+282,544
New +$11M 0.01% 544

Other funds holding BATRK

T. Rowe Price Investment Management's BATRK Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Atlanta Braves Holdings Series B (BATRK) stake by 20% in Q2 2026, selling an estimated $15.1M and leaving 1,225,091 shares worth $63.6M. The position accounts for 0.04% of the portfolio, ranked #355.

T. Rowe Price Investment Management first reported a position in BATRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $84.2M in Q2 2025. 326 funds tracked by Wall St. Rank hold BATRK as of Q2 2026.

  • T. Rowe Price Investment Management held 1,225,091 shares of Atlanta Braves Holdings Series B worth $63.6M as of Q2 2026.
  • T. Rowe Price Investment Management sold 308,558 Atlanta Braves Holdings Series B shares in Q2 2026, an estimated $15.1M.
  • Atlanta Braves Holdings Series B made up 0.04% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #355 holding.
  • T. Rowe Price Investment Management first reported a position in Atlanta Braves Holdings Series B in Q2 2024 and has held it in 9 quarters since.
  • T. Rowe Price Investment Management's Atlanta Braves Holdings Series B position peaked at $84.2M in Q2 2025.
  • 326 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.